Implantable brain device aims to tame Drug-Resistant seizures

NCT ID NCT07301346

Not yet recruiting Disease control Sponsor: Precisis US, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called EASEE® that is implanted under the skin and above the skull to stimulate the brain and reduce seizures in people with drug-resistant focal epilepsy. Two hundred adults will receive the implant, and half will have the stimulation turned on for 6 months to compare seizure reduction. The goal is to see if the device is safe and effective over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: implantable brain stimulator (EASEE® System)
What this could lead to: If it works, this could offer a new, minimally invasive option to reduce seizures in people with epilepsy that doesn't respond to medication.
What could go wrong: This is an early pivotal study with 200 participants, so results may not apply to everyone. Risks include surgical complications and the device may not reduce seizures for all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT FOCAL EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy focal epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DRUG-RESISTANT FOCAL EPILEPSY

More trials for these conditions

Other studies related to the condition(s) this trial covers.